Literature DB >> 17094003

Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis.

Muharrem Dagli1, Filiz Sivas Acar, Hayriye Karabulut, Adil Eryilmaz, Esra Erkol Inal.   

Abstract

The aim of this study was to investigate cochlear functions in patients with ankylosing spondilitis (AS). Prospective, case control study. Twenty-eight AS patients (56 ears) and 25 healthy control subjects (50 ears) were included in the study. Pure-tone audiometry at 250, 500, 1,000, 2,000, 4,000, 6,000 Hz and immittance measures including tympanometry and acoustic reflex and DPOAEs (Distortion Product Otoacoustic Emission) testing were performed in the patients and controls. Pure-tone audiometry findings of the patients and controls were significantly different in all frequencies (P < 0.05). Sensorineural hearing loss was found in 10 patients (35%) that was bilateral in seven and unilateral in three patients. On DPOAE testing, there was no statistically significant difference between the levels of noise floor of the patients and controls (P > 0.05). However, the DPOAE responses of the patients and controls were significantly different in 3,000, 4,000, 5,000 and 6,000 Hz frequencies (P < 0.05). There is a damage of outer hair cells in patients with AS, and damaged outer hair cell regions mostly corresponds to the basal and mid-portions of the cochlea.

Entities:  

Mesh:

Year:  2006        PMID: 17094003     DOI: 10.1007/s00296-006-0249-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report.

Authors:  S W Yeo; S N Park
Journal:  Otolaryngol Head Neck Surg       Date:  2001-07       Impact factor: 3.497

2.  STUDIES ON EXPERIMENTAL ALLERGIC (ISOIMMUNE) LABYRINTHITIS IN GUINEA PIGS.

Authors:  T YOSHIHIKO; S YUKIHIRO
Journal:  Acta Otolaryngol       Date:  1964-07       Impact factor: 1.494

Review 3.  Guidelines for screening for hearing impairment and middle ear disorders.

Authors: 
Journal:  ASHA       Date:  1989-01

4.  Elaboration of systemic immunity following inner ear immunization.

Authors:  J P Harris; N K Woolf; A F Ryan
Journal:  Am J Otolaryngol       Date:  1985 May-Jun       Impact factor: 1.808

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Immunology of the inner ear: response of the inner ear to antigen challenge.

Authors:  J P Harris
Journal:  Otolaryngol Head Neck Surg       Date:  1983-02       Impact factor: 3.497

7.  Inner ear immunology.

Authors:  G Mogi; H Kawauchi; M Suzuki; N Sato
Journal:  Am J Otolaryngol       Date:  1985 May-Jun       Impact factor: 1.808

8.  Stimulated acoustic emissions from within the human auditory system.

Authors:  D T Kemp
Journal:  J Acoust Soc Am       Date:  1978-11       Impact factor: 1.840

9.  Factors influencing collagen-induced autoimmune ear disease.

Authors:  T J Yoo; R A Floyd; N Sudo; T Ishibe; T Takeda; K Tomoda; Y Yazawa; J Stuart; I S Choe; S C Ha
Journal:  Am J Otolaryngol       Date:  1985 May-Jun       Impact factor: 1.808

10.  Arthritis of the middle ear in ankylosing spondylitis.

Authors:  M Magarò; G Ceresia; A Frustaci
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

View more
  9 in total

1.  Audio-vestibular evaluation in patients with essential tremor.

Authors:  Hatice Balaban; Emine Elif Altuntaş; Ismail Onder Uysal; Ilteriş Ahmet Sentürk; Suat Topaktaş
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-29       Impact factor: 2.503

2.  Association of systemic lupus erythematosus with hearing loss: a systemic review and meta-analysis.

Authors:  Vasileios Paraschou; Nikolaos Chaitidis; Zoi Papadopoulou; Patroklos Theocharis; Pavlos Siolos; Charalampos Festas
Journal:  Rheumatol Int       Date:  2021-02-03       Impact factor: 2.631

3.  Hearing and cochlear function of patients with ankylosing spondylitis.

Authors:  Orhan Kemal Kahveci; Umit Secil Demirdal; Abidin Duran; Ali Altuntas; Vural Kavuncu; Erdogan Okur
Journal:  Clin Rheumatol       Date:  2012-04-17       Impact factor: 2.980

4.  The impact of ankylosing spondylitis on audiovestibular functions.

Authors:  Zeliha Kapusuz Gencer; Mahmut Özkırış; Ilhan Günaydın; Levent Saydam
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-06       Impact factor: 2.503

5.  Vestibular evoked myogenic potentials in patients with ankylosing spondylitis.

Authors:  Abdulkadir Özgür; Münevver Serdaroğlu Beyazal; Suat Terzi; Zerrin Özergin Coşkun; Engin Dursun
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

6.  Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.

Authors:  Nazim Bozan; Mahmut Alpaycı; Mehmet Aslan; Hakan Cankaya; Ahmet Faruk Kıroglu; Mahfuz Turan; Abdurrahman Ayral; Emre Senkoy; Server Ilter
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-31       Impact factor: 2.503

7.  Evaluation of auditory and cochlear functions in ankylosing spondylitis patients according to the site of involvement.

Authors:  Duran Karataş; İsmail Doğan; Adnan Ekinci; Abdurrahman Yetiş; Müge Özcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-09       Impact factor: 2.503

8.  Medial olivocochlear reflex in ankylosing spondylitis patients.

Authors:  M S Beyazal; A Özgür; S Terzi; M Çeliker; E Dursun
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

9.  Evaluation of Hearing and Outer Hair Cell Function of Cochlea in Patients With Psoriatic Arthritis.

Authors:  Mehmet Akdag; Derya Uçmak; Fazıl Emre Özkurt; Mehtap Bozkurt; Zeynep Meltem Akkurt; İsmail Topçu
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-08-13       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.